Keywords: vertex, gw, begin, pediatric, 141w94, trial, pharmaceuticals

Vertex And GW Begin Pediatric 141W94 Trial

Article | 17 July 1997

Print This

Vertex Pharmaceuticals and Glaxo Wellcome have initiated a Phase IIItrial to evaluate the safety and efficacy of the protease inhibitor 141 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in